Antwort

Wir bedanken uns für das Interesse von Baukloh et al. an unserer Kostenanalyse zur Aneuploidieuntersuchung von Eizellen mittels Polkörperdiagnostik (PKD) im Kontext der assistierten Reproduktion.

• Literatur

• 1 Neumann K, Griesinger G. An Economic Analysis of Aneuploidy Screening of Oocytes in Assisted Reproduction in Germany. Geburtsh Frauenheilk 2020; 80: 172-178
• 2 Verpoest W, Staessen C, Bossuyt PM. et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Hum Reprod 2018; 33: 1767-1776 doi:10.1093/humrep/dey262
• 3 Geraedts J, Montag M, Magli MC. et al. Polar body array CGH for prediction of the status of the corresponding oocyte. Part I: clinical results. Hum Reprod 2011; 26: 3173-3180 doi:10.1093/humrep/der294
• 4 Zuidgeest MGP, Goetz I, Groenwold RHH. et al. GetReal Work Package 3. Series: Pragmatic trials and real world evidence: Paper 1. Introduction. J Clin Epidemiol 2017; 88: 7-13 doi:10.1016/j.jclinepi.2016.12.023
• 5 Harton GL, Magli MC, Lundin K. et al. European Society for Human Reproduction and Embryology (ESHRE) PGD Consortium/Embryology Special Interest Group. Best practice guidelines for polar body and embryo biopsy for preimplantation genetic diagnosis/screening (PGD/PGS). Hum Reprod 2011; 26: 41-46 doi:10.1093/humrep/deq265